Kidney transplantation in type 2 diabetic patients: a comparison with matched non-diabetic subjects

被引:39
作者
Boucek, P
Saudek, F
Pokorna, E
Vitko, S
Adamec, M
Koznarova, R
Lanska, V
机构
[1] Inst Clin & Expt Med, Ctr Diabet, Prague, Czech Republic
[2] Inst Clin & Expt Med, Transplant Ctr, Prague, Czech Republic
关键词
kidney transplantation; outcome; type 2 diabetes mellitus;
D O I
10.1093/ndt/17.9.1678
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Because they generally are older and frequently have co-morbidities, patients with type 2 diabetes mellitus and end-stage renal disease seldom are selected for renal transplantation. Thus, information on transplantation results from controlled studies in this high-risk category of patients is scarce. We have compared the results of kidney transplantations in type 2 diabetic patients with carefully matched non-diabetic subjects. Methods. All first cadaveric renal transplants performed in type 2 diabetic patients from January 1, 1988 to December 31, 1998 in our centre were included. Non-diabetic controls were individually matched with diabetic patients with respect to year of transplantation, sex, age, selected immunological parameters, and graft cold ischaemia. Results. We included 64 type 2 diabetic and 64 non-diabetic patients who were followed for a mean period of 37+/-27 and 41+/-31 months, respectively, after renal transplantation. Patient survival at I and 5 years post-transplant was 85 and 69 vs 84 and 74% (P=0.43, NS), while graft survival rates censored for patient death were 84 and 77 vs 82 and 77% for diabetic and non-diabetic subjects, respectively (P=0.52, NS). With graft survival results not censored for death with functioning graft, no significant change was seen (diabetic vs non-diabetic group: 77 and 54 vs 73 and 61%, P=0.19, NS). Age, but not the presence of diabetes, was the only factor significantly affecting patient survival when both patient groups were pooled. With regard to post-transplant complications requiring hospitalization, there was a significant difference only in the number of patients who had amputations (diabetic vs non-diabetic group: 8 vs 0, P=0.01). Conclusions. Patient and graft survival after kidney transplantation was similar in type 2 diabetic and matched non-diabetic subjects, with more amputations occurring in the diabetic group. Thus, at a single-centre level renal transplantation results almost equivalent to those in non-diabetic patients may be achieved in type 2 diabetes mellitus.
引用
收藏
页码:1678 / 1683
页数:6
相关论文
共 50 条
[31]   Predictive value of triglyceride/glucose index for cardiac outcomes in non-diabetic renal transplant recipients [J].
Karabulut, Dilay ;
Karabulut, Umut ;
Kalyoncuoglu, Muhsin ;
Katkat, Fahrettin ;
Berber, Ibrahim .
ACTA CARDIOLOGICA, 2024, 79 (03) :319-326
[32]   Predictors of progression of diabetic nephropathy: implication for timing of kidney transplantation [J].
Cheng, SS ;
Wilson, DM ;
Munn, SR .
CLINICAL TRANSPLANTATION, 1997, 11 (04) :334-336
[33]   Outcomes of pancreas transplantation in older diabetic patients [J].
Montagud-Marrahi, Enrique ;
Molina-Andujar, Alicia ;
Pane, Adriana ;
Jose Ramirez-Bajo, Maria ;
Amor, Antonio ;
Esmatjes, Enric ;
Ferrer, Joana ;
Musquera, Mireia ;
Diekmann, Fritz ;
Ventura-Aguiar, Pedro .
BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)
[34]   Prospective study on renal outcome of IgA nephropathy superimposed on diabetic glomerulosclerosis in type 2 diabetic patients [J].
Mak, SK ;
Wong, PN ;
Lo, KY ;
Tong, GMW ;
Wong, AKM .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (06) :1183-1188
[35]   KIDNEY TRANSPLANTATION AND DISTAL SPLENORENAL VENOUS ANASTOMOSIS IN THE TREATMENT OF DIABETIC NEPHROPATHY [J].
Piminova, T. A. ;
Salmayer, A. A. ;
Shraer, T. I. ;
Putincev, A. M. ;
Syomina, S. A. ;
Galcovsky, N. K. ;
Lucenko, V. A. .
VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2010, 12 (01) :45-50
[36]   Remarkable Improvement of Diabetic Nephropathy in Transplanted Allograft after Kidney Transplantation [J].
Tanaka, Ryo ;
Imamura, Ryoichi ;
Matsumura, Soichi ;
Fukae, Shota ;
Taniguchi, Ayumu ;
Nakazawa, Shigeaki ;
Yamanaka, Kazuaki ;
Namba-Hamano, Tomoko ;
Kakuta, Yoichi ;
Takao, Tetsuya ;
Fushimi, Hiroaki ;
Nonomura, Norio .
NEPHRON, 2024, 148 (07) :468-473
[37]   31P-magnetic resonance spectroscopy (31P-MRS) detects early changes in kidney high-energy phosphate metabolism during a 6-month Valsartan treatment in diabetic and non-diabetic kidney-transplanted patients [J].
Paolo Fiorina ;
Roberto Bassi ;
Chiara Gremizzi ;
Andrea Vergani ;
Rossana Caldara ;
Alessandra Mello ;
Alessandro Del Maschio ;
Francesco De Cobelli ;
Gianluca Perseghin ;
Antonio Secchi .
Acta Diabetologica, 2012, 49 :133-139
[38]   31P-magnetic resonance spectroscopy (31P-MRS) detects early changes in kidney high-energy phosphate metabolism during a 6-month Valsartan treatment in diabetic and non-diabetic kidney-transplanted patients [J].
Fiorina, Paolo ;
Bassi, Roberto ;
Gremizzi, Chiara ;
Vergani, Andrea ;
Caldara, Rossana ;
Mello, Alessandra ;
Del Maschio, Alessandro ;
De Cobelli, Francesco ;
Perseghin, Gianluca ;
Secchi, Antonio .
ACTA DIABETOLOGICA, 2012, 49 :S133-S139
[39]   Early Histologic Lesions and Risk Factors for Recurrence of Diabetic Kidney Disease After Kidney Transplantation [J].
Nyumura, Izumi ;
Honda, Kazuho ;
Tanabe, Kazunari ;
Teraoka, Satoshi ;
Iwamoto, Yasuhiko .
TRANSPLANTATION, 2012, 94 (06) :612-619
[40]   POST-STROKE USE OF PIOGLITAZONE IMPROVES ATHEROTHROMBOTIC HEMISPHERIC STROKE OUTOME IN NON-DIABETIC ABDOMINALLY OBESE PATIENTS [J].
Delva, M. I. .
WORLD OF MEDICINE AND BIOLOGY, 2013, 41 (04) :28-31